OVERVIEW

Part III in the BHRT Workshop Series Solve Troubling Symptoms is organized by TruBalance Healthcare and will be held from Nov 04 - 06, 2022 at Newpark Resort, Salt Lake City, Utah, United States of America.

Description:
Clinical cases will be analyzed to decide upon the appropriate treatments and level of care provided to patients. In BHRT Parts I & II, the cases and studies are simple and straightforward. However, a thorough understanding of BHRT Parts I and II is necessary to understand many of the more complex cases presented in BHRT Part III.
Extensive literature summaries that provide credence and support are presented so that providers have all the available data to defend their practice if necessary. There are many examples of studies that justify BHRT. For example, one study showed that standard statin treatments for cholesterol caused more cancer occurrence than PremPro®. Progesterone causes decreased absorption of estrogen, yet it can be anticipated and prevented. Each of these controversial topics and more will be thoroughly addressed.

Course Objectives:
Upon completion of this workshop the healthcare professional will be able to:
• Discuss the most current literature for bio-identical hormone replacement therapy (BHRT), including thyroid, testosterone, DHEA, estrogen, and progesterone.
• Determine the risks and benefits of transdermal estrogen vs. oral, when and why to use one over the other, and review the statistics that claim HRT increases blood clots…or does it?
• Examine current policy statements for hormone replacement therapy by the North American Menopause Society (NAMS) and American College of Obstetricians and Gynecologists (ACOG), with a critique and review of their recommendations.
• Describe rational approaches for the use of progesterone in treating PMS and PPD.
• Discuss new therapies for prostate cancer, as well as better diagnostic sensitivity and specificity of MRI-S scan. Learn the treatment rationale for prostate cancer survivors through case presentations and literature review.
• Determine current management strategies for preventing loss of pregnancy in Polycystic Ovary Syndrome (PCOS), as well as improving pregnancy rates in women with PCOS. Learn about the importance of maintaining low levels of aldosterone with PCOS.
• Examine literature reviews as to what level of Vitamin D helps protect against cancer, CAD, osteoporosis, dementia, type II DM, and AMD. Learn how to treat Vitamin D deficiency and how much is too much.
• Discuss the pathophysiology of vaginal atrophy and the use of rings, tabs, troches, creams, and DHEA.
• Discuss the importance of sex hormone-binding globulin (SHBG) in men and women and why it is predictive of CAD, MS, and cancer.
• Describe the data demonstrating that androgen suppression therapy and estrogen deprivation are associated with poor survival in men in comparison with placebo.
• Describe the difference in blood clot risk between Premarin®, Provera®, esterified estradiol, and micronized progesterone as per JAMA.
• Recognize the data demonstrating that only certain types of estrogen increase the production of fatty acid esters that protect against atherosclerosis and plaque deposition at the blood vessel wall.
Identify the inverse relationship between estrogen and prostate cancer and the two mechanisms by which estrogen treats and protects against prostate cancer.
• Demonstrate skills in multiple case studies with interactive discussion to ensure interpretation and treatment protocols are as demonstrated in our evidenced-based scientific literature.
• Examine the medical literature to understand how hormones affect cardiovascular disease for both men and women.
In addition to the clinical skills learned in this course, group discussions contribute to the collaborative nature of pharmacists working with physicians and nurse practitioners, and their patients to determine a personalized approach to prescribing HT. This collaborative process provides a continuum of care for patients in ensuring improved patient outcomes and consistency in care.